Heritas Capital’s newly launched Growth Fund III leads US$20m Series B round in Jio Health, Vietnam’s leading human-centered and technology-powered healthcare provider
Heritas Capital, through its newly launched Heritas Growth Fund III (HGF III), is pleased to have led the US$20m Series B round in Jio Health, a leading provider of human-centered, technology-powered healthcare in Vietnam. Other investors included Fuchsia Ventures, Kasikorn Bank Group and existing investor Monk’s Hill Ventures.
This fundraise represents the largest in the Jio Health’s history and will build on company’s aggressive growth. The Series B investment in Jio Health will extend its clinical service offering to more consumers and employers, support the launch of additional Smart Clinics in existing and new geographies, expand provider and clinical support teams, and further advance technology platform innovation.
“Jio Health is building a unique healthcare model with a blend of online and in-person service offerings to care for patients throughout their healthcare journey, from wellness to treatment and post-treatment recovery. We are pleased to support Jio Health in their mission to provide greater access to affordable quality healthcare solutions and managed care for all,” said Chik Wai Chiew, CEO and Executive Director of Heritas Capital.
Investment into Jio Health is made through Heritas’ newly launched HGF III, as the third completed investment under the fund. In prior funds, Heritas has backed leading digital health ventures across the region including Holmusk (Singapore), MFine (India) and Alodoktor (Indonesia).
Read about Jio Health’s plans to expand its national footprint across Vietnam on the company’s press release as well as other media outlets DealStreetAsia, TechInAsia, and The Business Times.